BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

875 related articles for article (PubMed ID: 28196257)

  • 1. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
    JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    Nangia J; Wang T; Osborne C; Niravath P; Otte K; Papish S; Holmes F; Abraham J; Lacouture M; Courtright J; Paxman R; Rude M; Hilsenbeck S; Osborne CK; Rimawi M
    JAMA; 2017 Feb; 317(6):596-605. PubMed ID: 28196254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy.
    Cigler T; Isseroff D; Fiederlein B; Schneider S; Chuang E; Vahdat L; Moore A
    Clin Breast Cancer; 2015 Oct; 15(5):332-4. PubMed ID: 25749072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scalp cooling successfully prevents alopecia in breast cancer patients undergoing anthracycline/taxane-based chemotherapy.
    Vasconcelos I; Wiesske A; Schoenegg W
    Breast; 2018 Aug; 40():1-3. PubMed ID: 29660543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COOLHAIR: a prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer.
    Smetanay K; Junio P; Feißt M; Seitz J; Hassel JC; Mayer L; Matthies LM; Schumann A; Hennigs A; Heil J; Sohn C; Jaeger D; Schneeweiss A; Marmé F
    Breast Cancer Res Treat; 2019 Jan; 173(1):135-143. PubMed ID: 30255454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia".
    Bajpai J; Kagwade S; Chandrasekharan A; Dandekar S; Kanan S; Kembhavi Y; Ghosh J; Banavali SD; Gupta S
    Breast; 2020 Feb; 49():187-193. PubMed ID: 31865282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia - A single center prospective study.
    Kate S; Patil R; Pathan D; Vyavhare R; Joseph S; Baby V; Ramesh YV; Nagarkar R
    Cancer Treat Res Commun; 2021; 26():100280. PubMed ID: 33338853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of scalp cooling in reducing alopecia in early breast cancer patients receiving contemporary chemotherapy regimens.
    Chan A; Bauwens A; Pontre S; Jackson S; McGlone F; Ernenwein T; Chih J; Reid C
    Breast; 2018 Oct; 41():127-132. PubMed ID: 30048865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
    Giarratano T; Frezzini S; Zanocco M; Giorgi CA; Mioranza E; Miglietta F; Griguolo G; Falci C; Faggioni G; Tasca G; Di Liso E; Vernaci G; Menichetti A; Mantiero M; Grosso D; Guarneri V; Dieci MV
    Breast J; 2020 Jul; 26(7):1296-1301. PubMed ID: 31837103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy.
    Rice BA; Ver Hoeve ES; DeLuca AN; Esserman LJ; Rugo HS; Melisko ME
    Breast Cancer Res Treat; 2018 Jan; 167(1):117-122. PubMed ID: 28921303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review.
    Marks DH; Okhovat JP; Hagigeorges D; Manatis-Lornell AJ; Isakoff SJ; Lacouture ME; Senna MM
    Breast Cancer Res Treat; 2019 Jun; 175(2):267-276. PubMed ID: 30806923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer.
    Carbognin L; Accetta C; Di Giorgio D; Fuso P; Muratore M; Tiberi G; Pavese F; D'Angelo T; Fabi A; Giannarelli D; Di Leone A; Magno S; Garganese G; Sanchez AM; Terribile DA; Franceschini G; Masetti R; Scambia G; Paris I
    Curr Oncol; 2022 Sep; 29(10):7218-7228. PubMed ID: 36290846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: a randomised trial in patients with breast cancer treated with adjuvant chemotherapy.
    Komen MMC; van den Hurk CJG; Nortier JWR; van der Ploeg T; Nieboer P; van der Hoeven JJM; Smorenburg CH
    Support Care Cancer; 2019 May; 27(5):1919-1925. PubMed ID: 30206728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience.
    Prochilo T; Huscher A; Andreis F; Mirandola M; Zaina E; Pomentale B; Pedrali C; Zanotti L; Mutti S; Zaniboni A
    Rev Recent Clin Trials; 2019; 14(1):66-71. PubMed ID: 30457055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy.
    Ohsumi S; Kiyoto S; Takahashi M; Hara F; Takashima S; Aogi K; Matsuda M; Yamamura N; Doi M
    Support Care Cancer; 2021 Jan; 29(1):437-443. PubMed ID: 32388615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines.
    Munzone E; Bagnardi V; Campennì G; Mazzocco K; Pagan E; Tramacere A; Masiero M; Iorfida M; Mazza M; Montagna E; Cancello G; Bianco N; Palazzo A; Cardillo A; Dellapasqua S; Sangalli C; Pettini G; Pravettoni G; Colleoni M; Veronesi P
    Br J Cancer; 2019 Aug; 121(4):325-331. PubMed ID: 31303642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
    Protière C; Evans K; Camerlo J; d'Ingrado MP; Macquart-Moulin G; Viens P; Maraninchi D; Genre D
    Support Care Cancer; 2002 Oct; 10(7):529-37. PubMed ID: 12324807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Scalp Cooling Have the Same Efficacy in Black Patients Receiving Chemotherapy for Breast Cancer?
    Dilawari A; Gallagher C; Alintah P; Chitalia A; Tiwari S; Paxman R; Adams-Campbell L; Dash C
    Oncologist; 2021 Apr; 26(4):292-e548. PubMed ID: 33512741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients.
    Ridderheim M; Bjurberg M; Gustavsson A
    Support Care Cancer; 2003 Jun; 11(6):371-7. PubMed ID: 12768403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients.
    Ohsumi S; Kiyoto S; Takahashi M; Takashima S; Aogi K; Shimizu S; Doi M
    Support Care Cancer; 2021 Oct; 29(10):6119-6125. PubMed ID: 33797582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.